Gene: LRRC59
Official Full Name: leucine rich repeat containing 59provided by HGNC
Gene Summary: Enables RNA binding activity and cadherin binding activity. Predicted to be involved in intracellular signal transduction. Located in endoplasmic reticulum and mitochondrial nucleoid. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00179 | LRRC59 gRNA1-gRNA2 KO plasmid | LRRC59 | $850 | |||
KO00595 | LRRC59 Knockout cell line(HCT 116) | Human | LRRC59 | 1:2~1:4 | Negative | Online Inquiry |
KO20218 | LRRC59 Knockout cell line (HeLa) | Human | LRRC59 | 1:3~1:6 | Negative | Online Inquiry |
KO20219 | LRRC59 Knockout cell line (HEK293) | Human | LRRC59 | 1:3~1:6 | Negative | Online Inquiry |
KO20220 | LRRC59 Knockout cell line (A549) | Human | LRRC59 | 1:3~1:4 | Negative | Online Inquiry |
LRRC59 Gene Knockout Cell Lines refer to a collection of genetically modified cell lines in which the LRRC59 gene has been deliberately inactivated or "knocked out." This product is designed for researchers seeking to investigate the biological functions and pathways associated with LRRC59, a gene implicated in various cellular processes, including cellular signaling and membrane trafficking.
The key function of these knockout cell lines lies in their ability to facilitate the study of LRRC59's role in cellular dynamics. By removing the LRRC59 gene, researchers can observe the resultant phenotypic changes, elucidating how its absence affects cellular behavior, protein interactions, and pathways, particularly in human-derived cell types. The mechanisms at play may include alterations in autophagy, immune response, and cellular proliferation, making it an essential tool for studying diseases where LRRC59 may play a pivotal role.
From a scientific perspective, these cell lines are invaluable in both basic and applied research settings. In research, they provide a unique platform for dissecting gene function and dissecting disease mechanisms. Clinically, they can enhance drug discovery efforts by identifying potential therapeutic targets or biomarkers. This capability to connect genetic modifications to specific biological outcomes is essential for translational research.
Compared to alternative cell lines, our LRRC59 Gene Knockout Cell Lines offer several distinct advantages. They are generated using precise CRISPR-Cas9 technology, ensuring a high degree of specificity and efficiency in gene editing. Furthermore, they are validated for consistent expression profiles and cellular responses, enabling reliable replication of experiments. This reliability reduces the variability often encountered with alternative genetic modification techniques.
For researchers and clinicians alike, the value of our LRRC59 Gene Knockout Cell Lines is immense. They streamline the investigation of gene function and interaction networks, which can lead to breakthroughs in understanding disease pathology and the development of novel therapeutic strategies.
Our company specializes in providing high-quality genetic tools for research and development, backed by a team of experienced scientists. We are committed to empowering your research with innovative solutions that meet the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.